Mantra Pharma Introduces the First Generic Alternative to CLAVULIN® (GSK) in Canada

BROSSARD, December 16, 2022 - Following an increase in cases of respiratory viruses, Canada is currently experiencing supply issues for an oral antibiotic for children, the CLAVULIN® from GSK. This shortage is being alleviated by the arrival of the very first generic drug from a Quebec company: M-Amoxi Clav offered by Mantra Pharma.

BROSSARD, 21 September, 2022 - Since the beginning of 2022, Mantra Pharma has launched several new products, planning to offer no less than six new molecules by December, one of which is M-Apixaban. The Quebec-based pharmaceutical company is ready for a very busy fall and has increased its portfolio to nearly 100 products.

LÉVIS, 10 January, 2021 - It is with great pride that Mantra Pharma’s Lévis team opened its new warehouse and business location The building already spreads out over 35,000 square feet and hosts 25 employees.